Concord Biotech Share Price

ABOUT Concord Biotech

• ISIN INE338H01029
• BSE Code 543960
• NSE Code CONCORDBIO

Concord Biotech Limited is an India-based research and development-driven biopharma company. The Company is engaged in the research and development, manufacturing, marketing, and selling of pharmaceutical products. Its business verticals include active pharmaceutical ingredients (API), finished formulations, and contract development and manufacturing services. It manufactures API through fermentation and semi-synthetic processes and finished formulations. The Company’s offerings span both biopharmaceutical APIs and formulations across therapeutic areas like immunosuppressants, oncology, anti-infectives nephrology, and critical care. Its portfolio also includes fermentation-based APIs in antibacterial, antifungal, and other therapeutic segments. Its API products include Mycophenolate Mofetil, Sirolimus, Pimecrolimus, Voclosporin, Mupirocin, Mupirocin Calcium, Vancomycin Hydrochloride, and Teicoplanin. Its API products under development include Daptomycin, Idarubicin, and Pirarubicin.

MANAGEMENT

• Sudhir Vaid Executive Chairman of the Board, Managing Director
• Ankur Vaid Chief Executive Officer, Joint Managing Director, Executive Director
• Lalit Sethi Chief Financial Officer
• Hina Patel Company Secretary and Compliance Officer
• Devang Bhatt Vice President - Sales and Marketing, Head - Limbasi Plant - 3
• Manoj Kumar Vice-President - Formulation Division and Head - Valthera Unit - 2
• Sundeep Bengani General Manager - International Business Development, Formulation Division